Glucose Monitoring for Type 2 Diabetes
Managing your glucose to help you reach your A1C goals is a 24/7 job. Find the support you need to manage type 2 diabetes with confidence. Empower yourself with educational resources and explore information on the latest diabetes technology to help you manage your diabetes with more confidence.
Living with Type 2 Diabetes
Put your well-being first
Living with type 2 diabetes (T2D) requires lifestyle changes that can feel overwhelming. Work with your doctor to build supportive routines that might include diet, movement, stress management, and sleep.1
Find personalized support
Everyone experiences T2D differently. Get guidance that’s tailored to your unique needs from your diabetes care team including your doctor, endocrinologist, diabetes nurse educator, or registered diabetes dietitian.2
Take care of your glucose levels
Tools like a continuous glucose monitoring (CGM) system can empower you to manage your glucose and lower your A1C to help you reduce the risk of long-term diabetes complications.2 Feel your best more often with continuous glucose monitoring.
Understanding Type 2 diabetes
About type 2 diabetes
T2D affects the way the hormone insulin functions in the body. Insulin allows our cells to absorb blood sugar, or glucose, and use it for energy. In T2D, the body no longer produces enough insulin or stops being responsive to the insulin that’s produced, known as insulin resistance. T2D is more common in those over 40.3
Type 1 diabetes vs. type 2 diabetes
T1D is caused by an autoimmune event that attacks the cells in the pancreas which produce insulin. This means there is no insulin in the body at all. T2D does not involve the destruction of these cells and those living with the condition continue to produce insulin.3,4
Treatments for type 2 diabetes
Lifestyle changes are an important part of managing blood glucose levels in individuals living with T2D. However, glucose lowering medications and insulin are often necessary for treating the condition.5 In some cases, treatment can lead to remission.6
Type 2 diabetes and glucose management
Individuals living with T2D are at risk of experiencing high blood sugar, known as HYPERglycemia. Those using insulin may also experience low glucose, known as HYPOglycemia. Keeping glucose levels in range can contribute to positive health outcomes.2
Take the next steps on your T2D journey
Connect with the diabetes community
You’re never alone when it comes to living with diabetes. Explore the Dexcom Warrior community to hear stories from individuals thriving with both T2D and T1D.
Educate yourself about type 2 diabetes
Understanding how diabetes impacts the body can empower you to take control of your diabetes management. Learn more about living with diabetes on the CGM Blog.
Glucose management FAQs
What does A1C mean?
What are normal blood sugar levels?
Is CGM better than a blood glucose meter for glucose management?
Dexcom G7 helps you reach your A1C goals
Unlike a blood glucose meter (BGM), the Dexcom G7 CGM System provides continuous, real-time glucose readings so you have the insight you need to take proactive action to manage your glucose.
No routine fingersticks*
Get painless, one-touch sensor application‡ and up to 10 days of wear, plus a 12- hour grace period to change sensors.
Real-time glucose readings
View continuous glucose readings in the palm of your hand on a receiver or compatible smart device with the Dexcom G7 app.†
Simple, intuitive experience
Gain a better understanding of your glucose readings and track your progress with easy-to-understand graphs and colourful arrows.
Proactive glucose alerts
Be in the know with alerts that can notify you the moment you go below 3.1 mmol/L and up to 20 minutes before a predicted low under 3.1 mmol/L.
Get started with Dexcom G7
Talk to your doctor about whether making the switch from your blood glucose meter to Dexcom G7 fits with your diabetes management plan.
* Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.
† Smart devices sold separately. For a list of compatible devices, please visit dexcom.com/compatibility.
‡ Patients reported 94% of insertions were painless (mild, no pain).
† Smart devices sold separately. For a list of compatible devices, please visit dexcom.com/compatibility.
‡ Patients reported 94% of insertions were painless (mild, no pain).
1 Type 2 treatment. Diabetes Canada. Accessed November 7, 2023. https://www.diabetes.ca/en-CA/about-diabetes/type-2/treatment
2 Imran AS, et. al. Can J Diabetes 2018:42(S42–S46)
3 Type 2 diabetes. Diabetes Canada. Accessed November 7, 2023. https://www.diabetes.ca/about-diabetes/type-2
4 Type 1 diabetes. Diabetes Canada. Accessed November 7, 2023. https://www.diabetes.ca/about-diabetes/type-1
5 What is diabetes? Diabetes Canada. Accessed November 7, 2023. https://www.diabetes.ca/about-diabetes/what-is-diabetes
6 Lean MEJ, et al. Lancet. 2018;391(10120):541-551.
7 Hyperglycemia and hypoglycemia in type 2 diabetes. Institute for Quality and Efficiency in Health Care. 2006. Updated October 20, 2022. https://www.ncbi.nlm.nih.gov/books/NBK279510/
8 Beck, RW, et al. JAMA. 2017;317(4):371-378.
9 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374.
10 Martens T, et al. JAMA. 2021;325(22):2262-2272.
11 Laffel LM, et al. JAMA. 2020;323(23):2388-2396.
12 Welsh JB, et al. J Diabetes Sci Technol. 2022:19322968221099879.
13 Heinemann L, et al. Lancet 2018;391 :1367-77.
2 Imran AS, et. al. Can J Diabetes 2018:42(S42–S46)
3 Type 2 diabetes. Diabetes Canada. Accessed November 7, 2023. https://www.diabetes.ca/about-diabetes/type-2
4 Type 1 diabetes. Diabetes Canada. Accessed November 7, 2023. https://www.diabetes.ca/about-diabetes/type-1
5 What is diabetes? Diabetes Canada. Accessed November 7, 2023. https://www.diabetes.ca/about-diabetes/what-is-diabetes
6 Lean MEJ, et al. Lancet. 2018;391(10120):541-551.
7 Hyperglycemia and hypoglycemia in type 2 diabetes. Institute for Quality and Efficiency in Health Care. 2006. Updated October 20, 2022. https://www.ncbi.nlm.nih.gov/books/NBK279510/
8 Beck, RW, et al. JAMA. 2017;317(4):371-378.
9 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374.
10 Martens T, et al. JAMA. 2021;325(22):2262-2272.
11 Laffel LM, et al. JAMA. 2020;323(23):2388-2396.
12 Welsh JB, et al. J Diabetes Sci Technol. 2022:19322968221099879.
13 Heinemann L, et al. Lancet 2018;391 :1367-77.